Xilin Li
- Molecular Biology
- Cancer Research
- Pharmacology top 10%
- Pharmacology
- Health, Toxicology and Mutagenesis
- Topics
- Carcinogens and Genotoxicity Assessment (7 papers)Cannabis and Cannabinoid Research (4 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Xilin Li
23 papers receiving 352 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 138
- Cancer Research 101
- Pharmacology 62
- Pharmacology 59
- Health, Toxicology and Mutagenesis 48
Countries citing papers authored by Xilin Li
This map shows the geographic impact of Xilin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilin Li more than expected).
Fields of papers citing papers by Xilin Li
This network shows the impact of papers produced by Xilin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilin Li. The network helps show where Xilin Li may publish in the future.
Co-authorship network of co-authors of Xilin Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xilin Li. A scholar is included among the top collaborators of Xilin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xilin Li. Xilin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 15 | |
| 7 | 28 | |
| 8 | 1 | |
| 9 | 23 | |
| 10 | 10 | |
| 11 | 13 | |
| 12 | 18 | |
| 13 | 15 | |
| 14 | 5 | |
| 15 | 19 | |
| 16 | 10 | |
| 17 | 31 | |
| 18 | 22 | |
| 19 | 24 | |
| 20 | 18 |
About Xilin Li
Xilin Li is a scholar working on Pharmacology, Cancer Research and Health, Toxicology and Mutagenesis, having authored 26 papers that have together received 359 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (7 papers), Cannabis and Cannabinoid Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Pharmacology (62 citations), Cancer Research (101 citations) and Biochemistry (31 citations). Xilin Li has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Nan Mei, Xiaoqing Guo, Ji‐Eun Seo, Lei Guo, Si Chen, Yuxi Li, Qiangen Wu, Supratim Choudhuri, Tong Zhou and Dongying Li. Their work appears in journals such as Molecular Cell, The Plant Journal and Frontiers in Plant Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.